← All trials
NCT01623336
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2012
- Primary completion
- Aug 1, 2016
- Completion date
- Dec 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 740
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Oswaldo Cruz FoundationLead sponsor
- NUCLIMEDStudy chair
- Federal University of Rio Grande do SulCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.